Print this article

Spray congealing: applications in the Pharmaceutical Industry

corresponding

PAULA CORDEIRO, MÁRCIO TEMTEM, CONRAD WINTERS*
*Corresponding author
Hovione, R&D, Drug Product Development Group, Sete Casas, 2674, 506 Loures, Portugal

Abstract

In this work, the potential of spray congealing in microencapsulation, taste masking and controlled release was explored and compared to other commonly used technologies, specifically spray drying and hot melt extrusion. The ability to control powder characteristics without the need of subsequent downstream processing methods is a marked advantage over other “particle-engineering” technologies. Moreover, spray congealing is an environmentally friendly process where high throughputs can be achieved. This technology involves some critical stages that should be thoroughly evaluated when establishing the process, namely the atomization, cooling and feed stages. Spray congealing represents a very attractive and promising platform to address some of the challenges related to drug development and drug life cycle management.


INTRODUCTION

The increasing demand for new formulations as part of drug life cycle management or to address New Chemical Entities challenges is boosting the use of spray congealing, which can be described as a combination of spray drying and hot melt extrusion techniques. This platform can match many of the systems prepared by spray drying or hot melt extrusion but also enables the preparation of powders with unique properties and applications in microencapsulation, taste masking and controlled release. The main goal of this paper is to provide an overview on the applications of spray congealing in the pharmaceutical industry and compare this technology, presenting the advantages and drawbacks, with others more commonly used like spray drying and hot melt extrus